Roy Jamron
Roy S. Jamron holds a B.S. in Physics from the University of Michigan and an M.S. in Engineering Applied Science from the University of California at Davis, and independently investigates the latest research on celiac disease and related disorders.
Articles by this Author
ActoGeniX Is Progressing Toward Celiac Disease Treatment
- By Roy Jamron
- Published 04/20/2008
- Celiac Disease Diagnosis, Testing & Treatment (Gluten-Free Diet)
-
Rating:




ActoGeniX is a recently formed Belgian company specializing in the development and use of genetically altered probiotic Lactococcus lactis bacteria designed to secrete and deliver therapeutic peptides and proteins to treat gastrointestinal disorders. Their product is called ActoBiotics™. Celiac disease is among the disorders ActoGeniX is currently investigating. Research has already shown efficacy in a celiac disease model where ActoBiotics™ continuously secrete small segments of gluten peptides to induce tolerance to gluten. Further research and trials are in the pipeline.
Durum Wheat Peptide Could Lead To Celiac Disease Treatment
- By Roy Jamron
- Published 02/10/2008
- Celiac Disease & Gluten Intolerance Research
-
Rating:




Researchers have found a 10mer durum wheat peptide capable of shifting a Th1 gluten-intolerant T cell response to a Th2 gluten-tolerant T cell response in intestinal T cell cultures derived from celiac disease children and incubated with deamidated gliadin peptides. Durum wheat peptides could potentially treat celiac disease by causing celiac disease associated T cells to react tolerantly to gluten.
New Improved Confocal Laser Endomicroscopy System
- By Roy Jamron
- Published 11/24/2007
- Celiac Disease Diagnosis, Testing & Treatment (Gluten-Free Diet)
-
Rating:




A new confocal laser microscopic probe has been developed by Mauna Kea Technologies which works in conjunction with conventional endoscopes providing real-time video sequences of the intestinal mucosa magnified 500-1000 times greater than the conventional endoscopic view.
Vitamin D Preserves the Intestinal Mucosal Barrier
- By Roy Jamron
- Published 11/2/2007
- Celiac Disease & Gluten Intolerance Research
-
Rating:




Researchers at the University of Chicago using vitamin D receptor
"knockout" mice demonstrated vitamin D may have a key role in
maintaining the intestinal mucosal barrier and the integrity of tight
junctions. The "knockout" mice were genetically altered to produce
mice lacking vitamin D receptors normally expressed by cells in most
body tissues.
Confocal Laser Endomicroscopy and Celiac Disease by Roy Jamron
- By Roy Jamron
- Published 11/7/2006
- Celiac Disease Diagnosis, Testing & Treatment (Gluten-Free Diet)
- Unrated
Celiac.com 11/07/2006 – We should be hearing
more about this in the news soon. A confocal...
The Role of Rotavirus in Celiac Disease by Roy Jamron
- By Roy Jamron
- Published 10/30/2006
- Celiac Disease & Gluten Intolerance Research
- Unrated
Celiac.com 10/30/2006 - Two recent scientific publications
have now shown that a rotavirus protein
Cognitive Impairment and Celiac Disease by Roy Jamron
- By Roy Jamron
- Published 10/12/2006
- Cognitive Impairment and Celiac Disease
- Unrated
Celiac.com 10/12/2006 - A new study examined Mayo
Clinic medical records for the years 1970 through
Is Celiac Disease Linked to Rotavirus Protein? By Roy Jamron
- By Roy Jamron
- Published 09/29/2006
- Celiac Disease & Gluten Intolerance Research
- Unrated
Celiac.com 09/29/2006 - A new study identified a
peptide which causes an immune reaction in a major
Cholesterol, Omega-3 Fatty Acids and Celiac Disease by Roy Jamron
- By Roy Jamron
- Published 09/12/2006
- Celiac Disease & Gluten Intolerance Research
-
Rating:




Celiac.com 09/12/2006 - Symptoms of celiac disease
prominently include fat malabsorption. One would
Older Celiac Disease Patients on a Gluten-Free Diet Slower to Recover by Roy Jamron
- By Roy Jamron
- Published 07/31/2006
- Celiac Disease & Gluten Intolerance Research
- Unrated
Celiac.com 07/31/2006 - A two-year study in the July
2006 Endoscopy showed older celiac patients

